Tamer M. Ibrahim

发表

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors.

A. Abadi, Tamer M. Ibrahim, K. Abouzid, 2009, Bioorganic & medicinal chemistry.

DDDT_A_224561 4247..4263

Tamer M. Ibrahim, F. Boeckler, Andreas Lange, 2019 .

Small-Molecule Intervention At The Dimerization Interface Of Survivin By Novel Rigidized Scaffolds

Tamer M. Ibrahim, F. Boeckler, Andreas Lange, 2019, Drug design, development and therapy.

Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.

Tamer M. Ibrahim, Rasha A. Nassra, Gina N Tageldin, 2019, Bioorganic chemistry.

HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker

Tamer M. Ibrahim, H. Shehata, Noura Alkhouly, 2013, Medical Oncology.

Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.

Tamer M. Ibrahim, F. Boeckler, Mohamed Fares, 2019, European journal of medicinal chemistry.

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing

Tamer M. Ibrahim, M. El-Hadidi, Ahmed E. Abdelkader, 2022, Virology.

Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors

Tamer M. Ibrahim, C. Supuran, C. Capasso, 2021, International journal of molecular sciences.

Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones

Tamer M. Ibrahim, A. Knethen, J. Bruning, 2019 .

Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents.

Tamer M. Ibrahim, A. Bekhit, Mai S El-Shoukrofy, 2018, Bioorganic chemistry.

Leishmania treatment and prevention: Natural and synthesized drugs.

Tamer M. Ibrahim, A. Shavandi, A. Bekhit, 2018, European journal of medicinal chemistry.

Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition

Tamer M. Ibrahim, K. Abouzid, Deena S. Lasheen, 2019, Journal of enzyme inhibition and medicinal chemistry.

New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations

Tamer M. Ibrahim, A. Bekhit, Afnan S. Batubara, 2022, Journal of enzyme inhibition and medicinal chemistry.

Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.

Tamer M. Ibrahim, I. M. El-Ashmawy, I. Chaaban, 2018, Bioorganic chemistry.

Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors.

Tamer M. Ibrahim, Wissam H. Faour, C. Daher, 2020, Bioorganic chemistry.

Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and in silico studies

Tamer M. Ibrahim, A. Bekhit, M. Mohamed, 2022, Journal of enzyme inhibition and medicinal chemistry.

Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents.

Tamer M. Ibrahim, A. Bekhit, Mai S El-Shoukrofy, 2017, Future medicinal chemistry.

Synthesis and antimicrobial activity of some novel 1,2-dihydro-[1,2,4]triazolo[1,5-a]pyrimidines bearing amino acid moiety

Tamer M. Ibrahim, A. Bekhit, M. Mohamed, 2021, RSC advances.

Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.

Tamer M. Ibrahim, Wagdy M. Eldehna, S. M. Abou-Seri, 2022, European journal of medicinal chemistry.

Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents.

Tamer M. Ibrahim, A. Bekhit, D. Ghareeb, 2019, European journal of medicinal chemistry.

Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents.

Tamer M. Ibrahim, A. Bekhit, D. Ghareeb, 2018, Future medicinal chemistry.

Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles

Tamer M. Ibrahim, A. Bekhit, A. El-Saghier, 2019, Medicinal Chemistry Research.

Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles

Tamer M. Ibrahim, A. Bekhit, A. El-Saghier, 2018, Medicinal Chemistry Research.

New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies.

Tamer M. Ibrahim, A. Bekhit, Ahmed Sabt, 2022, European journal of medicinal chemistry.

Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors.

Tamer M. Ibrahim, W. M. Hussein, A. Bekhit, 2020, Bioorganic chemistry.

Syntheses and in silico pharmacokinetic predictions of glycosylhydrazinyl-pyrazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]triazolo[4,3-a]pyrimidines as anti-proliferative agents

Tamer M. Ibrahim, A. Bekhit, Tareq Al-Shargabi, 2019, Medicinal Chemistry Research.

Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents.

Tamer M. Ibrahim, A. Bekhit, Tareq Al-Shargabi, 2017, Future medicinal chemistry.

Structure-guided approach on the role of substitution on amide-linked bipyrazoles and its effect on their anti-inflammatory activity

Tamer M. Ibrahim, K. H. Abd El Galil, S. Domiati, 2022, Journal of enzyme inhibition and medicinal chemistry.

Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative.

Tamer M. Ibrahim, A. A. El-Fattah, A. Bekhit, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.

Tamer M. Ibrahim, W. Fayad, S. Bondock, 2020, Bioorganic & medicinal chemistry.

In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches

Tamer M. Ibrahim, Wagdy M. Eldehna, Sara T. A. Al-Rashood, 2021, Journal of enzyme inhibition and medicinal chemistry.

Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia.

Tamer M. Ibrahim, H. Shehata, M. Ahmed, 2012, Clinical biochemistry.

Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors.

Tamer M. Ibrahim, C. Supuran, C. Capasso, 2021, European journal of medicinal chemistry.

Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.

Tamer M. Ibrahim, A. von Knethen, J. Bruning, 2019, European journal of medicinal chemistry.

Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study

Muhammad I. Ismail, Tamer M. Ibrahim, A. Bekhit, 2021, Computers in Biology and Medicine.

In-Silico Comparative Analysis of Egyptian SARS CoV-2 with Other Populations: a Phylogeny and Mutation Analysis

Omar Soliman, Mohamed El-Hadidi, Lamis Sharawy, 2020, 2020 2nd Novel Intelligent and Leading Emerging Sciences Conference (NILES).

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking

Frank M. Boeckler, Matthias R. Bauer, Tamer M. Ibrahim, 2020, Frontiers in Chemistry.

Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities

Tamer M. Ibrahim, M. El-Miligy, A. Hazzaa, 2023, Journal of enzyme inhibition and medicinal chemistry.

In Silico Targeting of Fascin Protein for Cancer Therapy: Benchmarking, Virtual Screening and Molecular Dynamics Approaches

Muhammad I. Ismail, Tamer M. Ibrahim, F. Boeckler, 2023, Molecules.

Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking

Muhammad I. Ismail, Tamer M. Ibrahim, F. Boeckler, 2021, Computers in Biology and Medicine.

Prognostic signi fi cance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia

Tamer M. Ibrahim, H. Shehata, M. Ahmed, 2012 .

Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation.

Tamer M. Ibrahim, A. Bekhit, Wagdy M. Eldehna, 2023, European journal of medicinal chemistry.

In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches

Tamer M. Ibrahim, Wagdy M. Eldehna, Sara T. A. Al-Rashood, 2021, Journal of Enzyme Inhibition and Medicinal Chemistry.

In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations

Tamer M. Ibrahim, H. Alkahtani, Wagdy M. Eldehna, 2021, RSC advances.

Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties.

Tamer M. Ibrahim, C. Supuran, Wagdy M. Eldehna, 2023, European journal of medicinal chemistry.

1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities.

Tamer M. Ibrahim, C. Supuran, H. Abdel‐Aziz, 2023, Journal of medicinal chemistry.

In silico screening of SARS-CoV2 helicase using African natural products: Docking and molecular dynamics approaches

Tamer M. Ibrahim, A. Bekhit, Wagdy M. Eldehna, 2023, Virology.

Patched Homolog Gene (PTCHI) As a Reliable Marker for Predicting Imatinib Response in Chronic Phase Chronic Myeloid Leukemia Patients in Correlation with Early Response to First Line of Treatment Imatinib

Tamer M. Ibrahim, N. Rakha, N. Abdalla, 2022, The Egyptian Journal of Hospital Medicine.

PPARg in complex with compound 4b

Tamer M. Ibrahim, A. Knethen, J. Bruning, 2019 .

Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents.

Tamer M. Ibrahim, A. Bekhit, Mai S El-Shoukrofy, 2017, Future medicinal chemistry.

Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer.

Tamer M. Ibrahim, C. Supuran, F. Şahin, 2023, European journal of medicinal chemistry.

Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells.

Tamer M. Ibrahim, Seyed-Omar Zaraei, T. Das, 2023, European journal of medicinal chemistry.